Navigation Links
Signalife's Dr. Harmison Launches Award-Winning Ambulatory Heart Monitor
Date:9/10/2007

LOS ANGELES, Sept. 10 /PRNewswire-FirstCall/ -- Flanked by prominent Board members Robert Windom, M.D. and Steven Phillips, M.D., Signalife's Dr. Lowell Harmison - in conjunction with inventor Dr. Budimir Drakulic - have this day initiated the product launch of the revolutionary, one-of-a-kind, FDA- approved, ambulatory 12-lead ECG cardiovascular monitor.

In private meetings throughout the United States over the next ten days, the trio of cardiovascular experts and Signalife's award-winning technology team will present the technologies to the marquee hospitals, facilities and physician-groups that Dr. Harmison has referred to since his recent appointment as acting CEO and President. Dr. Harmison has indicated that he anticipates the product launch to generate significant movement of both devices and technologies nationwide.

Dr. Harmison commented: "I am gratified that our Board has chosen to be personally involved in my initial product launch of the miraculous Fidelity 100 heart monitor. Additionally, it is extremely important and powerful to initiate our product launch with the actual inventor - and multiple Crump Award prize winner - Dr. Budimir Drakulic, whose inventions are legendary . . . from the Air Force EEG studies to winning the Frost & Sullivan Award after completing the initial Signalife device . . ., personally present at all of the institutions and locales."

"We will be visiting more than a dozen hospitals with thousands of beds and hundreds of physicians, beginning now, in cities nationwide. These are persons we know whose reputations and business successes precede them. I am personally excited about what I call our 'insider product launch' and I am thankful to Signalife's shareholders, Board members and staff for supporting the Company through the transition and thus making this possible. I will report back to the marketplace after this launch is completed.

"For more information on Dr. Harmison's initial product launch, whether from prospective purchasers of the technologies or from investors, Dr. Harmison has asked that the Company be contacted directly or through its investor relations personnel - particularly Mr. Kevin Kading.

About Signalife:

Signalife, Inc. is an award-winning life sciences company focused on the monitoring and detection of disease through continuous biomedical signal monitoring. Signalife uses its patented signal technology to design and develop medical devices that simplify and reduce the costs of diagnostic testing and patient monitoring in an ambulatory setting.

Signalife is publicly traded on the American Stock Exchange under the symbol SGN. The website for the company is http://Signalife.com. Clear Data. Trusted Results.

Caution Regarding Forward-Looking Statements:

Statements in this release that are not strictly historical are "forward- looking" statements. Forward-looking statements involve known and unknown risks, which may cause Signalife's actual results in the future to differ materially from expected results. Factors which could cause or contribute to such differences include, but are not limited to, failure to complete the development and introduction of heart monitoring and other biomedical devices incorporating Signalife's technology, failure to obtain federal or state regulatory approvals governing heart monitoring and other biomedical devices incorporating Signalife's technology, inability to obtain physician, patient or insurance acceptance of for heart monitoring and other biomedical incorporating Signalife's technology, and the unavailability of financing to complete management's plans and objectives, including the development of heart monitoring and other biomedical incorporating Signalife's technology. These risks are qualified in their entirety by cautionary language and risk factors set forth and to be further described in Signalife's filings with the Securities an Exchange Commission.


'/>"/>
SOURCE Signalife, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Merge launches diagnostic mammography workstation in Europe
2. Einstein Wireless launches cellular alert system
3. Logistics Health launches compliance management tool
4. UW-Madison launches new high-speed research network
5. UWM launches research foundation
6. TeraMedica launches information manager
7. GE Healthcare launches hybrid electronic record
8. Cedara launches new version of DICOM toolkit
9. Merge launches Spanish version of imaging tool
10. Doyle launches 2025 alternative energy plan
11. Jellyfish launches comparative shopping website
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/6/2019)... ... November 06, 2019 , ... Diversified Technologies, Inc. has introduced a ... per hour to improve processing. , The DTI Industrial PEF Unit can pre-treat whole ... increase juice yields by up to 50% and achieve up to an 80% reduction ...
(Date:11/2/2019)... ... October 31, 2019 , ... A clinical trial usually involves ... study managers, principal investigators, supply chain managers, manufacturers, IRT, CRAs and so on. ... the latest data, potentially leading to patient risk. , By having a single ...
(Date:10/29/2019)... (PRWEB) , ... October 28, 2019 , ... CaroGen ... Board: , , Professor Jack R Wands, MD, of Brown ... Wyeth (Pfizer) , Professor Gil Mor, MD, PhD, of Wayne State University, ...
(Date:10/22/2019)... ... , ... Catalent, a global leader in clinical supply services, today announced that ... in a panel session titled “Cell and Gene Therapy Logistics” at the upcoming Health ... on Oct. 28-30, 2019. , The panel session, on Wednesday, Oct. 30 at 8:30 ...
Breaking Biology Technology:
(Date:11/14/2019)... ... ... Personalized Stem Cells, Inc (“PSC”), a human adipose-derived stem cell company, ... stem cell treatment of knee osteoarthritis . The first treatment came shortly after the ... , In July of 2019, PSC received FDA approval for a New ...
(Date:11/12/2019)... ... 12, 2019 , ... Atlantic Ultraviolet Corporation (AUV), the premier ... voted their patented automatic and manual wipers the #1 best feature of the ... maintenance task required of an ultraviolet water purifier is quartz sleeve cleaning. A ...
(Date:11/6/2019)... , ... November 06, 2019 , ... ... Donald Stanski, MD, a senior pharmaceutical industry executive with expertise in clinical pharmacology ... for drug and disease strategic data analytics, has joined the firm as an ...
Breaking Biology News(10 mins):